Skip to main content
. 2016;48(1):27–34.

Table 1.

TAH patient demographics.

Patient Age Gender Weight (kg) Pre-ECMO VAD Infection Transplant (days) Alive
  1 58 Male   75 No  No No    Yes (110) No
  2 63 Male   76 Yes  No No    Yes (218) Yes
  3 33 Female   92 Yes  No No    Yes (18) Yes
  4 42 Male   75 No  HM II No    Yes (51) Yes
  5 62 Male   77 No  No No    No Yes
  6 60 Male 100 No  No No    Transferred Yes
  7 52 Male   82 No  cRVAD No    Yes (129) Yes
  8 55 Male   85 No  No No    Yes (98) Yes
  9 61 Male   87 No  HM II Yes    Wait List (185) No
10 49 Male   81 Yes  No No    Yes (276) Yes
11 58 Male   99 Yes  Impella No    Yes (159) Yes
12 57 Male 112 No  HM II No    Wait list (208) Yes
13 61 Male   91 No  No Yes    Wait list (63) Yes
Percent Yes 31% 38% 15%   62% 77%

Pre-ECMO Yes denotes ECMO support before TAH implant. VAD is ventricular support device use before implantation. Infection Yes is septicemia. HM II is Thoratec Heart Mate II (Thoratec Corporation, Pleasanton, CA). cRVAD is centrifugal pump right ventricular assist and Impella (Abiomed, Danvers, MA) is AbioMed left ventricular assist. Numbers in parenthesis denote number of days of support.